SPRAVATO® nasal spray adult patient

SPRAVATO®, the only FDA-approved nasal spray for adult patients with two forms of challenging-to-treat major depressive disorder (MDD):

  • Adults with MDD who’ve had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD)
  • Depressive symptoms in adults with MDD with suicidal thoughts or actions (MDSI)

See Limitations of Use below

Nasal spray icon

Why
SPRAVATO®

If you’ve taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression (TRD).

Click arrow icon
Calendar with checkmark icon

Getting Started
on SPRAVATO®

If you have treatment-resistant depression (TRD), you may benefit from adding SPRAVATO® to your current oral antidepressant.

Click arrow icon
Cost support icon

Cost Support
& Education

Find a nearby SPRAVATO® treatment center and be prepared with our list of common insurance questions relating to SPRAVATO® coverage.

Click arrow icon